Who to call at Mangoceuticals, Inc., and when
Fundz watches for the moments Mangoceuticals, Inc. starts buying, and tells you who to reach.
- An alert the day Mangoceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mangoceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mangoceuticals, Inc.. With Fundz connected, it knows.
Mangoceuticals, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
www.mangorx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Mangoceuticals secured $1.25 million in funding from accredited investors through its subsidiary MangoRx IP Holdings, with a 12.5% equity stake sold in two tranches to finance development of its antiviral technology platform MGX-0024.
Key Takeaways
MangoRx IP Holdings entered into Subscription Agreements with two accredited investors on September 30, 2026
One investor purchased a 12.5% stake for $1,250,000 with staggered payments: $500,000 immediately and $750,000 later
2 more takeaways
Filing Overview
What This Means
Mangoceuticals, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.